As Beijing and Washington exchange harsh words over President Donald Trump’s renewed threat of additional tariffs on $200 billion worth of Chinese imports, China is preparing to open up its pharmaceutical market further for a neighbor that it hasn’t historically had a good relationship with.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,